FDA Approves Long-Lasting HIV Prevention Injection
TL;DR
The FDA has approved lenacapavir, a long-acting injectable HIV prevention drug that is nearly 100% effective with just two doses per year, representing a significant advancement in HIV prevention, though its high cost may limit access in low-income regions.
- The FDA Just Approved a Long-Lasting Injection to Prevent HIV WIRED
- FDA approves powerful HIV prevention drug: What to know about Yeztugo NBC News
- Regulators Approve Lenacapavir for H.I.V. Prevention nytimes.com
- HIV prevention drug hailed as a 'breakthrough' gets FDA approval : Goats and Soda NPR
- The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it AP News
Want the full story? Read the original reporting
Read on WIRED